NOVEMBER 20, 2026 18:26Three years after the massacre at the Nova music festival site on October 7, 2023, what does it mean for a survivor to recover?For Prof. Rachel Yehuda, a trauma researcher at the Icahn School of Medicine at Mount Sinai in New York City, helping someone get through the week can be valuable work. It is also different from helping them reach a point where trauma no longer governs their life.At a time when people are experiencing the live consequences of the attack, and when the circumstances around them make it difficult to feel safe, this distinction is critical. It matters, too, when considering treatments whose promise may generate expectations – well before clinicians know whom they will help, under what conditions, and for how long.These questions ran through SafeHeart’s second annual conference, held last Wednesday (November 11) at the Peres Center for Peace and Innovation in Jaffa. Researchers, clinicians, survivors, and relatives gathered to discuss trauma, psychedelics, and the role of community in recovery.Yehuda urged particular caution about treating festival survivors with psychedelics. For people who may have been under the influence when the massacre began, another altered experience should not automatically become the first approach to treatment, she suggested.RONEN SHALEV, the father of Roei Shalev, speaks during an interview at the conference. (credit: Menash Cohen)The desire for relief is understandable, she explained, but an experience that offers escape and one that helps a person work through trauma are not necessarily the same thing.What is SafeHeart?SafeHeart, founded as an emergency mental health initiative on October 7, 2023, has developed its work around the particular needs of Nova survivors, including those who endured extreme violence while under the influence of psychoactive substances. Understanding that experience is part of treating its aftermath; the treatment itself does not necessarily involve administering psychedelic drugs.For Yehuda, who directs Mount Sinai’s Parsons Research Center for Psychedelic Healing, the discussion about psychedelic treatment must include how therapists are trained, how patients are prepared, and how they are supported afterward. She argued that any Israeli approval process for psychedelic medicines should address the psychological care accompanying their use – rather than focusing only on the drugs.“Supportive psychological care is an essential part of treatment with psychedelic drugs,” she said.Training therapists and defining appropriate care, she argued, must happen before patterns of treatment become well-established.Alongside those clinical questions, researchers presented findings intended to help explain why some survivors continue to struggle and whether those at greater risk could be identified earlier.Research presented by University of Haifa professors Roee Admon and Roy Salomon forms part of a project involving 1,268 survivors. Admon heads the university’s Stress and Psychopathology Research Lab, while Salomon also serves on SafeHeart’s board and leads its research work.The broader observational study follows survivors from the weeks after the attack to approximately two years later, with a comparison group drawn from the Israeli trance music community. It combines questionnaires and biological measurements to examine how people fare over time.One analysis presented at the conference found that survivors with higher levels of a protein involved in inflammation, measured in saliva early after the attack, tended to report more severe post-traumatic stress symptoms later. The association remained even after researchers accounted for how severe their symptoms had been at the outset.The researchers clarified that the finding is preliminary and has not yet been published. They said its potential application lies in the future: the results need to be replicated and the underlying mechanism better understood.A separate analysis examined survivors’ use of psychoactive substances in the months after the attack.Among 453 survivors surveyed eight to 12 months afterward, about 70% reported using more than one type of psychoactive substance, including alcohol.What the researchers were examining was patterns of use and the reasons behind them. Another analysis used a language model to examine survivors’ accounts of what they had taken, how they experienced it, and the effects they attributed to different substances.Those accounts may help researchers formulate questions, but they cannot establish what a drug did to someone’s recovery. Participants chose what to take; researchers did not assign them substances. An association between substance use and mental health cannot, on its own, determine which influenced which.For clinicians, understanding what patients are taking and why nevertheless belongs within the broader picture of their lives. Seeking relief, seeking escape, and seeking treatment may overlap, but they are not interchangeable.The scale of survivors’ continuing distress was clear in findings presented by Prof. Yuval Neria, a professor of clinical medical psychology at Columbia University and director of trauma and PTSD at the New York State Psychiatric Institute.In a study of 392 Nova survivors assessed twice during the first year after the attack, about 67% scored above a screening threshold for probable PTSD at one to five months. At eight to 12 months, about 65% were above that threshold.Looking at individuals’ symptom patterns showed that roughly 29% had persistently high symptoms, and that in 26%, their symptoms worsened. Together, they accounted for about 55% of the group. About a quarter followed a course of relatively low symptoms, described by researchers as resilient, while a fifth partially improved.These are first-year findings, not a measure of the conditions of the survivors three years later. They are based on symptom questionnaires, rather than individual clinical diagnoses, but they do show why the passage of time cannot be assumed to bring steady improvement, and why the saying “time heals all wounds” does not necessarily hold up in this case.Neria also discussed the importance of childhood trauma and sleep in understanding patients’ vulnerability and treatment needs. In the same study, childhood adversity and poorer sleep after the attack were associated with lower odds of following a resilient course. He urged clinicians to ask about sleep and address difficulties early.His presentation also examined distress that involves guilt and a loss of trust. He described “moral injury” as lasting distress following experiences that violate deeply held moral beliefs or expectations.For Nova survivors, he explained, this can include guilt about being alive when friends were killed or taken hostage, anguish over being unable to help, and a sense of betrayal after waiting hours for rescue. Such guilt obviously does not mean a survivor was responsible for what happened, but it can nevertheless shape how they understand their survival and whether they feel able to trust others.The practical implication for clinicians, he emphasized, is to ask about guilt, shame, and anger alongside fear. Rebuilding a life after the attack may involve repairing a sense of connection to other people, as well as addressing memories of danger.The attack itself is part of the clinical picture, but so are the conditions in which a person must live afterward.Prof. Merav Roth, a clinical psychologist, psychoanalyst, and co-founder of First Line Med, which provides free long-term treatment for people affected by October 7, brought a further dimension to the discussion.Across generations, she said, families can transmit resources for resilience as well as the effects of trauma.The conference program gave those relationships considerable space. Sessions addressed parents’ support groups, the experience of mothers of survivors, and community approaches to care.Continuity of care, commitment for yearsSafeHeart’s services include individual therapy, groups, retreats, and support for relatives.For Ronen Shalev, whose son Roei survived the festival and died by suicide in October 2025, the difficulty of recognizing distress was painfully personal.Speaking at the conference, Shalev described the distance between what he could see outwardly and his son’s suffering.He spoke about not knowing which tools to ask for, and urged those working with survivors to actively seek out people who were struggling.His account underscored how much can remain unknown even to those closest to a survivor, and how important it is that relatives also know where to turn for help.SafeHeart CEO Efrat Atun said research should help make care more responsive to survivors’ needs, while reinforcing the importance of sustaining it over time.“It takes continuity of care and a commitment that lasts for years,” she said.Three years after the attack, researchers are still examining why symptoms persist, how substance use fits into survivors’ lives, and whether biological measurements can help identify those who need closer attention.For families and clinicians, those questions sit alongside the daily work of supporting someone whose needs may change over time.Getting through the week can be a meaningful achievement; Yehuda’s distinction leaves another goal in view: reaching a point where trauma is part of a person’s life without continuing to govern it.Follow us on Google
Three years after the Nova massacre on October 7, what does recovery look like?
Full Article
Original Source
Read the full article at Jpost →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.